Exhibit 99.2

CRANE CO.

Income Statement Data

(in thousands, except per share data)

	Three Months Ended June 30,						Six Months Ended June 30,
	2006			2005			2006			2005
Net Sales:
Aerospace & Electronics	$	144,438		$	133,940		$	286,878		$	267,521
Engineered Materials		82,345			79,194			168,295			159,992
Merchandising Systems		53,625			45,687			106,182			89,440
Fluid Handling		253,848			245,917			499,196			474,468
Controls		24,007			20,967			47,250			41,483
Intersegment Elimination		(112	)		(86	)		(268	)		(224	)
Total Net Sales	$	558,151		$	525,619		$	1,107,533		$	1,032,680
Operating Profit:
Aerospace & Electronics	$	26,173		$	18,268		$	48,647		$	34,218
Engineered Materials		13,151			18,286			28,890			35,144
Merchandising Systems		4,462			4,052			8,214			7,833
Fluid Handling		30,019			20,033			54,376			32,457
Controls		2,960			1,817			5,552			3,577
Corporate		(10,675	)		(7,558	)		(22,372	)		(16,481	)
Total Operating Profit		66,090			54,898			123,307			96,748
Interest Income		903			161			1,611			502
Interest Expense		(5,496	)		(5,742	)		(11,023	)		(11,462	)
Miscellaneous- Net *		4,422			1,784			5,681			2,066
Income Before Income Taxes		65,919			51,101			119,576			87,854
Provision for Income Taxes		21,456			15,427			37,714			27,182
Net Income	$	44,463		$	35,674		$	81,862		$	60,672
Share Data:
Net Income per Diluted Share	$	0.71		$	0.59		$	1.32		$	1.01
Average Diluted Shares Outstanding		62,338			60,091			62,192			60,060
Average Basic Shares Outstanding		60,995			59,606			60,876			59,527
Supplemental Data:
Cost of Sales	$	376,423		$	363,333		$	747,923		$	714,975
Selling, General & Administrative		115,638			107,388			236,303			220,957
Depreciation and Amortization **		11,532			12,499			26,797			24,843
Stock Compensation Expense		4,037			1,920			8,119			4,873

* Second quarter 2006 miscellaneous- net includes a net gain of $4.1 million consisting of $8.3 million from the sales of Resistoflex Aerospace and Westad offset by $4.2 million from the sale of unused property resulting from prior plant consolidations and certain legal costs associated with previous divestitures.

** Amount included within cost of sales and selling, general & administrative costs.

CRANE CO.

Condensed Balance Sheets

(in thousands)

	June 30, 2006		December 31, 2005
ASSETS
Current Assets
Cash and Cash Equivalents	$	100,164	$	180,392
Accounts Receivable		336,291		289,521
Inventories		284,206		272,354
Other Current Assets		50,082		56,128
Total Current Assets		770,743		798,395
Property, Plant and Equipment		260,928		263,791
Insurance Receivable - Asbestos		216,449		224,600
Other Assets		329,435		284,345
Goodwill		664,578		568,355
Total Assets	$	2,242,133	$	2,139,486
LIABILITIES AND SHAREHOLDERS’ EQUITY
Current Liabilities
Notes Payable and Current Maturities of Long-Term Debt	$	188	$	254
Accounts Payable		153,964		149,647
Current Asbestos Liability		55,000		55,000
Accrued Liabilities		174,037		174,366
Income Taxes		19,163		19,322
Total Current Liabilities		402,352		398,589
Long-Term Debt		294,033		293,248
Deferred Tax Liability		75,168		71,406
Long-Term Asbestos Liability		509,599		526,830
Other Liabilities		98,517		96,119
Shareholders’ Equity		862,464		753,294
Total Liabilities and Shareholders’ Equity	$	2,242,133	$	2,139,486

CRANE CO.

Condensed Statements of Cash Flows

(in thousands)

	Three Months Ended June 30,						Six Months Ended June 30,
	2006			2005			2006			2005
Operating Activities:
Net income	$	44,463		$	35,674		$	81,862		$	60,672
Income from joint venture		(1,458	)		(1,384	)		(3,219	)		(2,582	)
Gain on divestitures		(8,267	)		—			(8,267	)		—
Depreciation and amortization		11,532			12,499			26,797			24,843
Stock-based compensation expense		4,037			1,920			8,119			4,873
Cash (used for) provided by operating working capital		(1,249	)		385			(34,148	)		(44,636	)
Other		1,002			2,155			5,198			3,133
Subtotal		50,060			51,249			76,342			46,303
Asbestos related payments, net of insurance recoveries		220			(8,434	)		(9,080	)		(19,258	)
Refund associated with terminated Master Settlement Agreement		—			—			—			9,925
Total provided by operating activities		50,280			42,815			67,262			36,970
Investing Activities:
Capital expenditures		(8,611	)		(5,800	)		(17,001	)		(11,375	)
Proceeds from disposition of capital assets		1,618			1,126			2,854			1,381
Proceeds from divestitures		25,880			—			25,880			—
Payment for acquisition, net of cash acquired		(63,727	)		—			(149,065	)		—
Total used for investing activities		(44,840	)		(4,674	)		(137,332	)		(9,994	)
Financing Activities:
Dividends paid		(7,669	)		(5,965	)		(15,292	)		(11,920	)
Common shares acquired on the open market		(12,958	)		—			(24,999	)		—
Stock options exercised - net of shares reacquired		10,247			115			18,643			1,876
Excess tax benefit from stock-based compensation		5,059			—			6,775			—
Repayment of debt, net		(74	)		(2,741	)		(276	)		(4,425	)
Total used for financing activities		(5,395	)		(8,591	)		(15,149	)		(14,469	)
Effect of exchange rate on cash and cash equivalents		3,618			(2,503	)		4,991			(3,610	)
Increase (decrease) in cash and cash equivalents		3,663			27,047			(80,228	)		8,897
Cash and cash equivalents at beginning of period		96,501			32,577			180,392			50,727
Cash and cash equivalents at end of period	$	100,164		$	59,624		$	100,164		$	59,624

* Gain from divestiture of Resistoflex Aerospace and Westad of $8.3 million when combined

CRANE CO.

Order Backlog

(in thousands)

	June 30, 2006		March 31, 2006		December 31, 2005		June 30, 2005
Aerospace & Electronics	$	380,514	$	364,539	$	365,010	$	370,913
Engineered Materials		18,617		16,972		17,241		15,964
Merchandising Systems		15,190		14,838		9,183		9,298
Fluid Handling		204,180		205,741		188,832		201,768
Controls		18,385		19,480		16,864		14,952
Total Backlog	$	636,886	$	621,570	$	597,130	$	612,895

CRANE CO.

Non-GAAP Financial Measures

(in thousands)

	June 30, 2006			December 31, 2005
BALANCE SHEET ITEMS
Notes Payable and Current Maturities of Long-Term Debt	$	188		$	254
Long-Term Debt		294,033			293,248
Total Debt		294,221			293,502
Less Cash and Cash Equivalents		(100,164	)		(180,392	)
Net Debt		194,057			113,110
Shareholders’ Equity		862,464			753,294
Total Capitalization	$	1,056,521		$	866,404
Percentage of Net Debt to Total Capitalization		18.4	%		13.1	%

	Three Months Ended June 30,						Six Months Ended June 30,						Year Ended December 31,
	2006			2005			2006			2005			2006			2005
													(Estimated)
CASH FLOW ITEMS
Cash Provided from Operating Activities before Asbestos - Related Payments	$	50,060		$	51,249		$	76,342		$	46,303		$	260,000		$	216,958
Asbestos Related Payments, Net of Insurance Recoveries		220			(8,434	)		(9,080	)		(19,258	)		(45,000	)		(45,338	)
Refund Associated with Terminated Master Settlement Agreement		—			—			—			9,925			—			9,925
Cash Provided from Operating Activities		50,280			42,815			67,262			36,970			215,000			181,545
Less: Capital Expenditures		(8,611	)		(5,800	)		(17,001	)		(11,375	)		(30,000	)		(27,164	)
Free Cash Flow	$	41,669		$	37,015		$	50,261		$	25,595		$	185,000		$	154,381

* Includes certain legal fees and expenses relating to the terminated Master Settlement Agreement amounting to $5.1 million for the full year of 2005, $4.1 million in the first six months of 2005 and $.5 million in the second quarter of 2005.

Certain non-GAAP measures have been provided to facilitate comparison with the prior year.

Free cash flow provides supplemental information to assist management and investors in analyzing the Company’s ability to generate positive cash flow. Free cash flow is considered a measure of cash generation and should be considered in addition to, but not as a substitute for, other measures reported in accordance with generally accepted accounting principles and may be inconsistent with similar measures presented by other companies.